This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Feb 2011

Prasco & Shire Enter Supply Deal

The Cincinnati-based pharmaceutical company Prasco announced its distribution and supply agreement with Shire US Manufacturing for mesalamine controlled-release capsules.

Prasco Laboratories has reached a distribution and supply contract with Shire US Manufacturing, Inc. for mesalamine controlled-release capsules.


Pending FDA approval, Prasco is prepared to market the generic version of Pentasa (mesalamine) Controlled-Release Capsules, at Shire's request. The authorized generic will be marketed in the U.S. in 250 mg and 500 mg strengths under the Prasco label.


"We are excited to have established this new business relationship with Shire," said Prasco chief executive officer, E. Thomas Arington."Patients and pharmacists alike benefit when a company such as Shire commits to maintaining the supply of brand-identical medication through the Prasco Authorized Generic business model."

Related News